We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

152 hedge funds and large institutions have $2.24B invested in Heron Therapeutics in 2018 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 54 increasing their positions, 39 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

147% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 19

79% more capital invested

Capital invested by funds: $1.25B → $2.24B (+$991M)

60% more funds holding in top 10

Funds holding in top 10: 5 → 8 (+3)

38% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 39

23% more funds holding

Funds holding: 124 → 152 (+28)

18.42% more ownership

Funds ownership: 107.15% → 125.57% (+18%)

10% more call options, than puts

Call options by funds: $39.4M | Put options by funds: $35.7M

Holders
152
Holders Change
+28
Holders Change %
+22.58%
% of All Funds
3.48%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.18%
New
47
Increased
54
Reduced
39
Closed
19
Calls
$39.4M
Puts
$35.7M
Net Calls
+$3.62M
Net Calls Change
-$7.32M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$49.3M
2
BBA
Baker Bros. Advisors
New York
+$44.6M
3
EAM
Eagle Asset Management
Florida
+$41.1M
4
ACH
ArrowMark Colorado Holdings
Colorado
+$34.7M
5
BM
Bridger Management
New York
+$29M

Top Sellers

1
CC
Carlson Capital
Texas
-$26.2M
2
Franklin Resources
Franklin Resources
California
-$26.2M
3
RCMNY
Rubric Capital Management (New York)
New York
-$15.6M
4
Citadel Advisors
Citadel Advisors
Florida
-$15M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$12.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$13.1M +$1.77M +78,244 +20%
FLAM
27
First Light Asset Management
Minnesota
$13.1M +$1.35M +59,554 +14%
Invesco
28
Invesco
Georgia
$12.5M -$2.77M -122,147 -21%
NC
29
Nexthera Capital
New York
$11.3M +$9.28M +409,000 New
PAM
30
Panagora Asset Management
Massachusetts
$10.7M +$643K +28,348 +8%
TC
31
Tavio Capital
New York
$9.71M +$7.98M +351,729 New
CC
32
Carlson Capital
Texas
$9.54M -$26.2M -1,155,814 -77%
SIM
33
Stelliam Investment Management
New York
$8.75M +$7.19M +317,000 New
Goldman Sachs
34
Goldman Sachs
New York
$8.62M +$3.78M +166,560 +114%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$7.71M +$1.79M +78,719 +39%
Charles Schwab
36
Charles Schwab
California
$7.45M +$614K +27,082 +11%
Citigroup
37
Citigroup
New York
$7.06M -$8.65M -381,135 -60%
JP Morgan Chase
38
JP Morgan Chase
New York
$6.7M -$962K -42,397 -15%
UBS Group
39
UBS Group
Switzerland
$6.04M +$4.07M +179,364 +455%
Bank of America
40
Bank of America
North Carolina
$5.88M +$3.6M +158,710 +293%
KAM
41
Kavi Asset Management
New York
$5.88M +$4.83M +212,900 New
TA
42
Teachers Advisors
New York
$5.65M +$2.76M +121,881 +147%
CAM
43
Cormorant Asset Management
Massachusetts
$5.28M -$202K -8,892 -4%
EI
44
EAM Investors
California
$4.97M +$4.08M +179,911 New
CCM
45
Cohen Capital Management
California
$4.42M +$3.18M +140,000 New
Morgan Stanley
46
Morgan Stanley
New York
$4.14M +$260K +11,464 +8%
QIM
47
Quantitative Investment Management
Virginia
$3.96M +$3.26M +143,600 New
MIM
48
Monashee Investment Management
Massachusetts
$3.59M +$2.95M +130,000 New
TCIM
49
TIAA CREF Investment Management
New York
$3.43M +$267K +11,765 +10%
CWG
50
C WorldWide Group
Denmark
$3.15M -$399K -17,590 -13%
1
2
3 4 5

HRTX Hedge Fund Activity: Q1 2018 in Review

152 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q1 2018, worth a combined $2.24B — up 79% from $1.25B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new HRTX positions and 19 closed out — a net gain of 28 holders — while 54 added to existing stakes and 39 trimmed.

The largest buyer was Wellington Management Group, opening a new position worth an estimated $49.3M. The largest seller was Carlson Capital, cutting an estimated $26.2M.

  • 152 institutional investors held Heron Therapeutics (HRTX) as of Q1 2018, up from 124 in Q4 2017.
  • Funds reported $2.24B of Heron Therapeutics stock for Q1 2018, up 79% quarter-over-quarter.
  • 47 funds opened new Heron Therapeutics positions in Q1 2018 and 19 closed out, a net change of +28 holders.
  • The largest Heron Therapeutics buyer in Q1 2018 was Wellington Management Group, an estimated $49.3M added.
  • The largest Heron Therapeutics seller in Q1 2018 was Carlson Capital, an estimated $26.2M sold.

Based on aggregated 13F filings for Q1 2018.